Xiong M, Zhu Y, Lai H, Fu X, Deng W, Yang C, He Q, Zheng G
A significant slowing of biological processes linked to age-related disease and all-cause mortality risk, as measured by the PCGrimAge epigenetic clock
The two hormonesGLP-1 and GIPplay different but complementary roles
Many studies have shown a link between the risk of cardiovascular diseases and the production of TMA by intestinal bacteria, which is further converted to trimethylamine N-oxide (TMAO) by hepatic enzymes (Tang et al
2,6 SGLT2i represent the first class of HF drugs targeting pathophysiological mechanisms different from neurohormonal activation and providing not only cardioprotective effects but also important metabolic benefits
Dosages may vary based on patient needs and provider protocol